# Definium Therapeutics, Inc.: Form 6-K, filed May 28, 2021

- Company: [Definium Therapeutics, Inc.](/companies/dftx.md) (CIK 1813814)
- Form: 6-K
- Filed: 2021-05-28
- Accepted by EDGAR: May 28, 2021, 16:23 ET
- Period: 2021-05-28
- Accession: 0001104659-21-074183
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1813814/000110465921074183/tm2117982d1_6k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1813814/000110465921074183/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1813814/000110465921074183/tm2117982d1_6k.htm

Filed May 28, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-074183. Last ingested by Listed: Nov 10, 2026, 02:38 ET. No prices; not investment advice.